VHL loss seems insufficient to induce ccRCC and additional second-hit genetic alterations have been identified in the mTOR pathway or chromatin modifying complexes such as PBRM1, SETD2, BAP1 among others11. Here, VHL is linked to nonpapillary renal cell carcinoma.